Brentuximab Vedotin + Re-induction Chemotherapy for AML
Clinical trial NCT01830777 · COMPLETED
Trial details
- NCT number
- NCT01830777
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2018-04-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.